Skip to main content
NewslettersWatchlist

Trevena Inc(TRVN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Trevena Inc

955 Chesterbrook Boulevard Suite 110
Chesterbrook PA 19087 USA
P: 610-354-8840
http://www.trevena.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and developing therapeutics for G protein coupled receptors. The Company's product pipeline includes TRV027, TRV130, TRV734 and Delta opioid biased ligand which are in different clinical phases. Trevena, Inc. is based in King of Prussia, Pennsylvania.

    Key Executives

    NameTitle
    Carrie L. BourdowCEO/Chairman of the Board/Director/President

    More from The Globe

    Dividend investing has lost its mojo. Here’s why – and how to adapt
    Ian McGugan
    The Globe Investing Club 2024: Let the competition begin!
    opinion
    Here’s the real reason your Canadian stocks can’t keep up
    Tim Shufelt
    Dow ends above 40,000 milestone, TSX also at fresh record high
    Traders work on the floor of the New York Stock Exchange (NYSE) on May 16.
    number cruncher
    U.S technology stocks with earnings and price momentum
    For Number Cruncher column in Globe Investor/ROB only.
    Lightspeed Commerce stock soars on better-than-expected profit forecast
    Lightspeed Commerce Inc. CEO Dax Dasilva poses in the company's offices in Montreal, Wednesday, May 8, 2024. THE CANADIAN PRESS/Christinne Muschi
    GameStop, AMC dive further as meme stocks rally tapers off
    A screen displays the trading information for GameStop and AMC Theatres on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 15.
    The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings
    The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.